To address these complex challenges, JBS deployed a next-generation Agentic AI for dynamic pricing in clinical trials, custom-built for vaccine development in early-phase research.
Context Agent
Ingests real-time global FMV, site performance data, and regulatory urgency to inform contextual pricing models.
Adaptive Cost Agent
Simulates and predicts dynamic pricing in clinical trials by modeling cost shifts tied to dosing schedules, lab preferences, and emerging safety metrics.
Contracting Agent
Generates AI-driven clinical trial contracts in real time, reducing site contracting time by over 70%.
Monitoring Agent
Tracks and flags trial budget anomalies and adjusts forecasts with real-time safety inputs for better cost predictability.